Impact of peptide receptor radionuclide therapy (PRRT) on the 68Ga-DOTATOC-PET/CT uptake in normal tissue

1378 - Objectives PET/CT with [68Ga]DOTA0-Phe1-Tyr3-octreotide (68Ga-DOTA-TOC) became a standard for somatostatin receptor imaging. We investigated the potential changes of normal tissue uptake in patients with neuroendocrine tumor undergoing peptide receptor radionuclide therapy (PRRT). - Methods S...

Full description

Saved in:
Bibliographic Details
Main Authors: Giesel, Frederik L. (Author) , Stefanova, Mesla (Author) , Afshar-Oromieh, Ali (Author) , Mier, Walter (Author) , Haberkorn, Uwe (Author) , Kratochwil, Clemens (Author)
Format: Article (Journal)
Language:English
Published: 2013 Feb. 1
In: The quarterly journal of nuclear medicine and molecular imaging
Year: 2013, Volume: 57, Issue: 2, Pages: 171-176
ISSN:1827-1936
Online Access:Verlag, lizenzpflichtig, Volltext: https://www.minervamedica.it/en/journals/nuclear-med-molecular-imaging/article.php?cod=R39Y2013N02A0171
Get full text
Author Notes:Frederik Giesel, Mesla Stefanova, Ali Afshar-Oromieh, Walter Mier, Uwe Haberkorn and Clemens Kratochwil
Search Result 1

Impact of peptide receptor radionuclide therapy (PRRT) on the 68Ga-DOTATOC-PET/CT uptake in normal tissue by Giesel, Frederik L. (Author) , Stefanova, Mesla (Author) , Afshar-Oromieh, Ali (Author) , Mier, Walter (Author) , Haberkorn, Uwe (Author) , Kratochwil, Clemens (Author) ,


Get full text
Article (Journal) Online Resource